Gutiérrez-Rodríguez A, Camacho-Arroyo I

Idioma: Español
Referencias bibliográficas: 39
Paginas: 109-115
Archivo PDF: 884.39 Kb.

RESUMEN

El factor de bloqueo inducido por progesterona (PIBF) es una proteína inmunomoduladora por medio de la cual la progesterona ejerce varios de sus efectos inmunológicos en diferentes células de alta proliferación, que incluyen desde células embrionarias hasta células tumorales. El PIBF ocasiona un incremento en la síntesis de anticuerpos asimétricos y de citocinas tipo Th2 como las interleucinas (IL) 4, 6 y 10, así como una disminución en la actividad citotóxica de las células NK y en la producción de citocinas tipo Th1, como el factor de necrosis tumoral alfa (TNFα) e IL-12. Lo anterior provoca una reducción en la relación Th1/Th2 que es característica del embarazo sano, lo que tiene como consecuencia un aumento en la inmunidad humoral y una disminución en la inmunidad celular. Estos mecanismos inmunomoduladores tienen como resultado una evasión del sistema inmune de la madre por parte del feto para que el embarazo llegue a término. De manera interesante, diversos estudios sugieren que estos mismos mecanismos son utilizados por las células cancerosas para facilitar la progresión de tumores que presentan sobre-expresión del PIBF.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Brunton, P.J. & Russell, J. The expectant brain: adapting for motherhood. Nat. Rev. Neurosci. 9, 11–25 (2008).

2. Melcangi, R.C., et al. Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions. Prog. Neurobiol. 113, 56–69 (2014).

3. Graham, J.D. & Clarke, C.L. Physiological action of progesterone in target tissues. Endocr. Rev. 18, 502-519 (1997).

4. Brinton, R.D., et al. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 29, 313-39 (2009).

5. Schumacher, M., et al. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 14 Suppl A, S18–S33 (2009).

6. Cabrera-Muñoz, E. Hernández, O.T. & Camacho-Arroyo, I. Role of progesterone in human astrocytomas growth. Curr. Top Med. Chem. 11, 1663-1667 (2011).

7. Finlay, J., et al. Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. Oncogene. 34, 3676-3687 (2015).

8. Szekeres-Bartho, J., et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol. 1, 1037–1048 (2001).

9. Szekeres-Bartho, J. Csernus, V. Hadnagy, J. & Pacsa, A.S. Immunosuppressive effect of serum progesterone during pregnancy depends on the progesterone binding capacity of the lymphocytes. J. Reprod. Immunol. 5, 81-88 (1983).

10. Szekeres-Bartho, J., et al. Immunoregulatory effects of a suppressor factor from healthy pregnant women’s lymphocytes after progesterone induction. Cell Immunol. 122, 281-94 (1989).

11. Camacho-Arroyo, I. & Rodríguez-Dorantes, M. Transcriptional activity regulated by progesterone receptor isoforms. Mol. Endocrinol. 661, 25-38 (2006).

12. Schumacher, M. et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors. Prog. Neurobiol. 113, 6-39 (2014).

13. Conneely, O.M. & Lydon J.P. Progesterone receptors in reproduction: functional impact of the A and B isoforms. Steroids. 65, 571-577 (2000).

14. Chen, J. The unique pharmacological characteristics of mifepristone (RU486): from terminating pregnancy to preventing cancer metastasis. Med. Res. Rev. 34, 979-1000 (2014).

15. Szekeres-Bartho, J. & Chaouat, G. Lymphocyte-derived progesterone-induced blocking factor corrects resorption in a murine abortion system. Am. J. Reprod. Immunol. 23, 26-28 (1990).

16. Szeredapy, L. Argaa, V. & Szekeres-Bartho, J. Cytokine Production by Lymphocytes in Pregnancy, Am. J. Reprod. Immunol. 38, 418-411 (1997).

17. Szekeres-Bartho, J., et al. Endocrine regulation of the immune system during pregnancy. Arch. Immunol. Ther. Exp. (Warsz). 38,125-140 (1990).

18. De la Haba, Carlos., et al. Oxidative stress effect on progesteroneinduced blocking factor (PIBF) binding to PIBF-receptor in lymphocytes. Biochim. Biophys Acta. 1838, 148-157 (2014).

19. Szekeres-Bartho, J., et al. Immunoregulatory effects of a suppressor factor from healthy pregnant women’s lymphocytes after progesterone induction. Cell Immunol. 122, 281-94 (1989).

20. Polgar, B., et al. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor. J. Immunol. 171, 5956-5963 (2003).

21. Lachmann, M., et al. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome. Int. J. Cancer. 112, 51-60 (2004).

22. Kim, K. & Rhee, K. The pericentriolar satellite protein CEP90 is crucial for integrity of the mitotic spindle pole. J. Cell Sci. 124, 338-347 (2011).

23. Kozma, N., et al. Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor. J. Immunol. 176, 819-826 (2006).

24. Srivastava, M.D, Thomas, A. Srivastava, B.I. & Check J.H. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymphoma. 48, 1610-1617 (2007).

25. Keats, N., et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701–738 (1999).

26. Darnell, J.E. Kerr, I.M. & Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264, 1415-1421 (1994).

27. Szekeres-Bartho, J. & Polgar, B. PIBF: the double edged sword. Pregnancy and tumor. Am. J. Reprod. Immunol. 64, 77-86 (2010).

28. Hudić, I., et al. Progesterone-Induced Blocking Factor and cytokine profile in women with threatened pre-term delivery. Am. J. Reprod. Immunol. 61, 330-337 (2009).

29. Szekeres-Bartho, J. Varga, P.P. & Pejtsik, B. ELISA test for the detection of an immunological blocking factor in human pregnancy serum. J. Reprod. Immunol. 16, 19-29 (1989).

30. Szekeres-Bartho, J. Wegmann, T.G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 31, 81-95 (1996).

31. Luchetti, C.G. Mikó, E. Szekeres-Bartho, J. Paz, D.A. & Motta, A.B. Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice. J. Steroid. Biochem. Mol. Biol. 111, 200-207 (2008).

32. Szekeres-Bartho, J., et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am. J. Reprod. Immunol. 35, 348-351 (1996).

33. Kelemen, K. Bognar, I. Paal, M. & Szekeres-Bartho, J. A Progesterone-Induced Protein Increases the Synthesis of Asymmetric Antibodies. Cell Immunol. 167, 129-134 (1996).

34. Szekeres-Bartho, J., et al. Increased NK activity is responsible for higher cytotoxicity to HEF cells by lymphocytes of women with threatened preterm delivery. Am. J. Reprod. Immunol. Microbiol. 7, 22-26 (1985).

35. Szekeres-Bartho, J. Kinsky, R. & Chaouat G. The effect of a progesterone induced immunologic blocking factor on NKmediated resorption. Am. J. Reprod. Immunol. 24, 105-107 (1990).

36. Faust, Z. Laskarin, G. Rukavina, D. & Szekeres-Bartho, J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am. J. Reprod. Immunol. 42, 71-75 (1999).

37. González-Arenas, A. Valadez-Cosmes, P. Jiménez-Arellano, C. López-Sánchez, M. & Camacho-Arroyo, I. Progesteroneinduced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway. J. Steroid. Biochem. Mol. Biol. 144, 463-470 (2014).

38. Merk, B.C, et al. STAT6 expression in glioblastoma promotes invasive growth. BMC Cancer. 20, 11:184 (2011).

39. Halasz, M. Polgar, B. Berta, G. Czimbalek, L. & Szekeres- Bartho, J. Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity. Cell Mol. Life Sci. 70, 4617-4630 (2013).